Search Conferences and Exhibitions

"Industry`s pipeline contains very few new antibiotics active against multidrug-resistant bacteria. Without stimulating research and development into new antibiotics, an increasing number of infected patients will be without effective treatment". Bo Aronsson, EMEA.

"A future without effective antibiotics will exacerbate a situation where already at least 25,000 patients in the EU each year die from infections due to multidrug-resistant bacteria. Patients suffering from healthcare-associated infections will be particularly hard hit" Dominique Monnet, ECDC

SMi`s 12th Annual Conference will bring you up to date with new and emerging products in the antimicrobials market, with a particular focus on antibacterials and antifungals and allow you to learn from and network with some of the leading individuals and organisations in this ever important area.

Key topics include:

• A global update on emerging antibiotic resistant pathogens 
• Developments in the emerging global challenge of bacterial multi-drug resistance 
• Tackling resistance in gram-negative bacteria 
• Forming strategic alliances with large pharma to develop new antibacterials 
• New approaches to fungal and protozoal infections  
• Insights into novel therapies for overcoming resistance

This seminar will show you how to draft and prosecute ONE patent applications which will comply with the differing requirements of BOTH the EPC and the USPTO.

There will be practical worked examples, illustrations, demonstrations of ‘best practice’ and plenty of discussion, ensuring that you will go home with a realistic and workable solution to a perennial problem.

5th Annual Pharmacovigilance conference will underpin processes and developments on many different elements including the regulatory and legislative framework, risk management, PSUR, live licensing, in drug safety and surveillance. With succinct themes, interactive sessions by key opinion leaders, our conference will bring latest insights, integrated strategies and best practices in pharmacovigilance.

The day is a mix of presentations on the subject, including detail about the specification itself and practical considerations for implementing the eCTD in your organisation. 

Topics to be covered include:-

• Introduction and overview of the eCTD
• What are the main components of the eCTD
• The ICH and European eCTD specifications
• Transitioning from paper submissions to the eCTD
• Considerations when selecting tools for the eCTD
• Process changes for the eCTD
• Practical experiences of submitting eCTDs

This course would be of maximum benefit to those safety professionals who are working both in the Clinical and Post-Marketing Safety arena. The course covers very diverse activities within the Safety Department and would be advantageous to those who have either multifunction responsibilities or Medical Directors who manage teams in the various disciplines.

Key Topics to be covered:

• Due Diligence
• Training for Drug Safety - Reporting Duties
• Audits and Expectations
• Compliance and Drug Safety
• Independent Data Monitoring Boards
• Product Safety Reviews – Purpose and Function
• Safety Reporting in Licensing Agreements
• Developing Company Core Safety Information – CIOMS III
• PSURs
• The EU Clinical Trial Directive
• Risk/Benefit Determinations
• CIOMS V
• Crisis Management

• Find out how the European Courts are handling pharmaceutical claims that are too broad
• Gain an update on EPO pharmaceutical and biotech case law
• Understand the legal implications of the Pharmaceutical Inquiry
• Improve your SPC knowledge and analyse recent developments
• Hear about the recent decisions in the US pharmaceutical sector
• Discuss employee compensation

• The new regulatory framework – what’s the latest and how should operators respond?
• Article 7 and community consultation procedures
• The role of the new regulators’ group BEREC
• Pricing regimes in bundled environments
• Spectrum policy, ‘refarming’ and spectrum allocation
• Wireless broadband access
• Ensuring maximum benefit from the digital dividend
• Next Generation Access: investment and regulation
• Regulatory and competitive challenges of NGNs and NGA
• Funding models of Next Generation competitive broadband
• Providing a balanced regulatory environment for Mobile Termination Rates (MTRs)
• Call termination and interconnection in an IP world
• The latest developments in competition law

Key topics that will be addressed on the agenda include:

• Determining how to identify and overcome traditional and Next Generation fraud challenges
• Developing an effective Revenue Assurance and Revenue Management strategy for new services and products
• Establishing how to evolve the Fraud Management System in order to develop an effective fraud control strategy for new services
• Understanding how to establish effective revenue leakage recovery strategies for different revenue streams
• Examining how to combat hacking at the traditional as well as IP PBX level
• Determining how to ensure an inherent Revenue Assurance culture across the entire business
• Understanding how to detect and prevent interconnection fraud
• Examining Revenue Assurance techniques for Fraud Detection, viruses and Malware

SMi`s LNG 2010 will bring together leading oil and gas companies, financiers and expert consultants from around the globe to discuss issues that are most relevant to the LNG industry today. The two day programme will explore the major projects in Europe, Australia, Asia and Africa covering the most imminent commercial, financial and technical aspects of LNG production and trade in a distressed environment. After attending this event, you will walk away with innovative business techniques that will help you ride out of the economic downturn and not just survive, but successfully thrive in this highly competitive market.

• Strategies for protecting your pharmaceutical inventions
• The complexities of listing a patent in the FDA Orange Book
• US claim strategies and US and Drug administration procedures
• US patent litigation
• An update on the ongoing debate on follow-on biologics in the US Congress

Who Should Attend?

• Patent Attorneys
• IP Managers
• Lawyers

• OFAC’s compliance expectations for US and non-US entities
• Working effectively with HM Treasury on obtaining licenses
• Designing effective systems and controls to prevent sanctions breaches
• Promoting economic sanctions awareness
• Preparing for greater enforcement of EU blocking measures

Is Your Company or Client Next?

Now more than ever, economic sanctions pose unprecedented compliance risks for financial institutions, insurers and exporters in Europe.

The US Treasury Department’s Office of Foreign Assets Control (OFAC) has stepped up its international enforcement efforts and is committed to ensuring all global companies carefully comply with US sanctions regulations no matter where located. The £231 million Lloyds TSB penalty, the largest fine ever imposed for violations of US sanctions regulations, ANZ Bank’s recent $5.75 million settlement as well as other investigations into the shipping industry, continue to serve as a harsh reminder of the magnitude of consequences for entities that violate US sanctions laws.

While ongoing OFAC investigations continue to grab headlines, European and foreign entities must also be ever mindful of UK and EU sanctions developments. The Financial Services Authority recently released a report on economic sanctions compliance to encourage all firms, large and small, to enhance compliance processes. Moreover, cooperation between US and European sanctions authorities is increasing and EU Member States are taking steps to tighten and enforce sanctions regulations.

Under this increased climate of risk, global companies and financial institutions operating in Europe must institute preventative measures and enhance existing compliance programmes. Failure to detect and prevent sanctions breaches is otherwise likely to result in staggering penalties and reputational damage.

Following the success of their Economic Sanctions conferences in London, Frankfurt and Washington, DC, American Conference Institute and C5 Group are pleased to introduce the 3rd European Forum on Economic Sanctions. Senior government officials, industry leaders and attorneys will once again provide insights on critical sanctions issues, including:

• OFAC’s compliance expectations for US and non-US entities
• Working effectively with HM Treasury on obtaining licenses
• Designing effective systems and controls to prevent sanctions breaches
• Promoting economic sanctions awareness
• Preparing for greater enforcement of EU blocking measures

This one day conference will include a series of presentations providing a practical guide to recognising and responding to the deteriorating patient improving the reliability of patient observations and benchmarking practice to ensure the safety of acutely ill patients on the wards.

Key topic include:

Designed for both the strategic view and the tactical approach, each year Police Forces and Authorities descend on London to networking and set their plans for the future performance management programmes. To quote one of 2009’s attendees, the annual conference is:

Driving & Capitalising on a 360° View of the Customer: Knowledge – Service – Performance – Profit

Tailored for those driving strategic growth across regional and global contact centres, the unique Exchange format provides Contact Centre, Customer Service, Customer Experience, CRM & Customer Strategy Executives with the, the opportunity to tackle key challenges in an open and frank discussion forum.

Why attend the Executive Customer Contact Exchange?

Through carefully selected keynote addresses, structured networking activities, intimate boardroom style discussions and one-to-one meetings with leading solution providers, find out how to:

• Design and deliver the right multi-channel contact strategy that meets your customers’ needs
• Streamline, consolidate and integrate operating processes without impacting your customers’ experience
• Ensure your outsourcer delivers the service your customers expect and the one your brand promises
• Maximise performance and profit from your people by empowering your workforce to drive change from the bottom-up
• Propel customer satisfaction scores to new heights by creating a customer obsessed culture
• Extract maximum value from the latest contact centre solutions including social media, mobile CRM, cloud computing, Web 3.0 and unified communications

Child and adolescent addictions will bring together leading experts in the fields of psychiatry, psychology and psychotherapy to discuss the current issues, latest developments and practical management of child and adolescent substance misuse.

It is anticipated that participants will benefit from:

• A comprehensive overview of the trends in adolescent substance misuse and addiction
• A greater understanding of the clinical consequences of substance misuse
• A review of the latest pharmacological and psychological treatment interventions
• A raised awareness of the current issues in child and adolescent addiction services and policies
• An opportunity to share and exchange ideas with leading practitioners in the field

Topics to be covered:

• Learn about the Drug Development Process – from Drug Discovery to Product Launch and Beyond
• Understand the background of European Law – Regulations, Directives, etc.
• Discover where you can find information on Regulatory Affairs, Approvals, Withdrawals, etc.
• What is the Centralised Procedure?
• Understand the EU Clinical Trial Directive
• How to Seek Scientific Advice in Europe
• What is the Common Technical Document

Chaired by Ian McPherson Director National Mental Health Development Unit this one day conference provides a practical guide to delivering Quality, Innovation, Productivity and Prevention in Mental Health. Jim Easton National Director for Improvement and Efficiency NHS Quality, Innovation, Productivity and Prevention (QIPP) opens the day with a focus on developments from the NHS Productivity Unit and the individuals role in supporting quality, innovation, productivity and prevention.

Topics to be covered:

• How to apply for a Marketing Authorisation in the EU
• Key Aspects of Safety Reporting
• Pharmacovigilance and GCP Inspections
• Managing Product Labelling
• Discuss Licence Variations
• Understand Parallel Imports & Generic Applications
• Managing a Regulatory Affairs Department

By attending this conference you will gain the latest insights into:
• The economic future of the global regenerative medicine market and acquiring venture capital
• The use of stem cell therapies in type 1 diabetes
• Small molecule drugs to stimulate neurogenesis and neuroprotection in Parkinson’s disease
• The use of direct stem cell therapies in cardiovascular diseases
• The use of direct stem cell therapies in wound healing
• The use of direct stem cell therapies in bone remodelling
• Gene therapy for retinal degeneration
• Scaling-up in the lab
• Scaling up in manufacturing
• Clinical trials for novel therapies
• How to commercialise your product
• Overcoming patent, legal and regulatory hurdles

Key Benefits:

• Stay up-to-date on the latest innovations in packaging and labelling
• Learn how can you turn a cost and hygiene factor into a commercial benefit?
• Examine new strategies in fighting counterfeiting
• Gain knowledge about legislation and existing models – EU, USA, Greece, Italy, Belgium, Turkey
• Find out about the supply chain security and compliance
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies

With a carefully designed agenda tailored to address financial planners` most pressing concerns, FinPlan provides you and all other Financial Planners with the tools you need to develop your business, including practical tips on how to:

• grow a successful recurring revenue business and increase profitability
• build and maintain productive relationships with your clients
• agree the appropriate remuneration for your services
• grow your company`s brand through a winning marketing campaign
• maximise efficiency by developing credentials, qualifying clients and systematising your workflow
• build scalability in your fee-based business for effective succession planning
• adopt the investment management approach that delivers best returns
• select the right technology to help you grow your business
• improve service offering by incorporating wraps into your business

SMi’s Legal Issues in Oil and Gas 2010 will bring together a collection of regulators, in-house counsel and private practice lawyers to provide comprehensive views and solutions needed to mitigate the legal risks surrounding the industry. Attendees will have the opportunity to hear discussions and network with our renowned international speakers.

Key topics to be addressed:

• Current legal issues in view of security of gas supply
• Mergers and acquisitions in a distressed market
• Resource nationalism: Latest developments, remedies and prevention
• Effectively identifying and mitigating risks when drafting energy contracts
• Legal issues in cross border oil and gas pipelines
• Legal issues in underground gas storage
• International obligations for decommissioning in oil and gas

• Drive Integrated Luxury Marketing Through Leadership For Greater Results In the High Net Worth Market
• Gain Affluent Demographic & Behavioural Insights To Create Relevant Customer Communications
• Expand International Horizons To Diversify Your Customer Base And Grow Your Market Share
• Identify The ROI Of Luxury Online Brand Activities, Ensuring You Best Invest Your Limited Budget
• Improve The Online Luxury User Experience To Drive Customer Engagement, Keeping Your Brand Top Of Mind

Take advantage of the networking opportunities and gain insights on:
• Evaluation of reimbursement mechanisms in the five major EU markets (France, Italy, Spain, Germany and UK)
• Opportunities to obtain higher reimbursement for innovative medical devices
• NICE health technology and device appraisals: Processes and people
• Developing a reimbursement strategy for introducing an innovative medical device into a prospective payment based system (DRG)
• Combining reimbursement and clinical expertise to realise clinical utility targets
• Market Access and funding for medical devices in Central Eastern Europe
• Maximising the value of CED from a device manufacturer perspective
• Assigning monetary value to innovative medical devices and diagnostic technologies

The topics of interest include but not limited to

•   Formal Methods and Notations for representing requirements
•   Requirements analysis theories, concepts, methods and techniques, and their practical applications
•   Business process and workflow modeling, analysis, integration and management
•   Requirements quality and adherence to standards
•   Requirements Quantification
•   Methodologies for information systems design and implementation
•   Applications, case studies, and management issues
•   Model and meta-model transformations
•   Computational independent models
•   Platform independent models
•   Formalized business process, methodologies
•   Integration within development frameworks
•   Approaches, frameworks, methodologies and standards for requirements analysis
•   Methodologies for information systems design and implementation
•   Evaluation and selection of tools
•   Organisational semiotics

• Discover how to increase your company`s ability to accelerate its rebound out of the financial crisis
• Understand the key decisions and tasks required for you to get started with one or more of these scenarios in your own organisation - customer data integration (CDI), product information management (PIM), or data governance
• Recognise what is driving business interest in MDM, CDI, PIM, and Data Governance solutions
• Establish what are the better architectures and vendors ... and how these solutions differ from data warehouse and CRM initiatives
• Learn how the market and key technologies evolve ... and who the leading vendors will be
• Confirm how an IT organisation gets started ... and how IT sells MDM to the business
• Create an action plan to establish a Data Governance programme
• Determine the most successful best practices for creating a "single customer view"... and how to decide to build, buy, or extend an MDM solution
• Add 250+ MDM experts to your professional social network and increase your personal net worth to your enterprise

• Are you currently involved in projects to bring down the cost of your network expenditure?
• Do you want to learn how the major Operator groups are developing internal offshoring initiatives to reduce costs?
• Do you want to hear how Mobile Operators have reduced their Network related spends by up to 25% through network sharing?
• Do you understand how to maximise cost-saving through managed services by outsourcing both the core and access network planning, operations and maintenance?
• Do you want to hear how the financial community can fund your network build?

If you have answered yes to any of the above, then make space in your diary for this key industry event.

This senior-level strategy forum will have CxO and Director level speakers from the major worldwide mobile operators.

Key topics to be addressed:

Whilst anti-corruption compliance is an issue for all major industry sectors, Pharma, Biotech and Medical Device companies are finding themselves particularly vulnerable when specific practices and industry customs are placed under the microscope. In the last 6 years, U.S. prosecutors have brought more than a dozen cases against drug makers for off-label marketing alone and won more than $6 billion in criminal and civil settlements. Estimates indicate that there are currently more investigations underway by the SEC and DOJ combined against medical device manufacturers than any other industry

As companies focus on steering themselves out of the economic downturn, they can ill afford a bribery and corruption probe as well. Reviewing and revising an effective corporate anti-corruption compliance policy will demonstrate to employees and, if necessary, regulators, that your company considers anti-corruption compliance to be an important corporate goal. If undertaken properly, anti-corruption compliance can be a valuable corporate asset that enhances company operations, facilitates compliance with law and mitigates damage when and if violations occur.

Don’t allow what has happened to other companies happen to your organisation.

With increased international co-operation, the potential for investigations is growing by the day. It has never been more important for the healthcare industry to benchmark their compliance programmes, compare operating practices and review internal anti-corruption procedures.

Hear from top industry experts and their advisors, including representatives from:

• Leading pharmaceutical, life sciences and medical device companies
• Key regulatory bodies
• Top international law firms

To this end, Osney Media’s Withholding Tax on US-sourced Income event on 20^th and 21^st April will provide a timely opportunity for all those affected by these sea-changes to benchmark with peers, and hear the thoughts of many of the global thought leaders in the field. It will be the best opportunity for the market to convene and find out just what is going on, what has changed, and how this will affect your individual roles and your company’s position. Planning ahead has never been more important.

Over 120 people attended the previous event on October 2009, and the impact of US government bills HR3933 and HR4213 (and any other relevant bills) means this event will be just as popular. The landscape has changed dramatically even since October, and you cannot afford to miss this opportunity, whether your focus is strategic, operational or legal. We look forward to helping you come to terms with the potential impacts – whatever they may be come April 2010!

There will be an opportunity to hear about new research involving the use of bronchodilators and kinase-inhibitors as well as antibody based biologics. Presentations will also cover topics such as new therapeutic targets in asthma and COPD and optimising respiratory clinical trial data.

• Hear about novel endpoints in COPD clinical trials
• Explore the application of in vitro cell models in drug development
• Learn about the use of the use of protein kinases as drug targets
• Discuss methods for candidate drug selection and risk management
• Network with industry associates and share experiences

Taking place in London, UK, this conference will focus on a wide range of issues withing the CSV arena, including the regulatory aspects to CSV - whether the current guidelines need expanding, reinterpreting or rewriting - CSV in an R&D context, the need for a risk-based approach to CSV, the respective benefits of doing CSV in-house or contracting it out, and developing a `bigger picture` approach to CSV.

Questions examined during the conference will include: what is the role of QA departments?  How much CSV is enough?  Does CSV hamper clinical R&D?  Should all CSV be risk-based in analysis?  Should the industry use a consortium approach to vendor-CSV audit?  Are consultants too widely used - would CSV be done better in-house?  What are the CSV implications for mergers?  How to develop a quality model?

Attend this event to discover how computer systems validation does not have to be difficult, time-consuming and costly, and to learn how to plan for better implementation of a CSV programme.

• ISPE Good Engineering Practice Guide
• Applicable Regulations
• Risk Management
• Practical application of science and risk based approach to process and system equipment verification
• Making best use of supplier documentation
• Understanding of terminology and the ‘busting’ of some myths
• Practical approach to documentation and document approvals
• Change management and how to gain acceptance of this
• Auditing
• Maintenance management
• Opportunity to take part in group exercises to use tools in real life examples

At the end of this seminar, participants will be able to:

• Balance expenditure and activity in relation to cost and benefits
• State a clear definition of good engineering practice
• Understand how the risk based approach will improve effectiveness and reduce costs
• Have a common understanding of the concept and principles of GEP
• Explain how GEP concepts may be applied in the healthcare industry
• Balance expenditure and activity against the associated risks and benefits of a defined scope of work

Combat Service Support Operations is designed to address the ever changing operational needs, technological aspects and challenges within the global support community.  This event brings together leading members of industry and senior military experts to discuss, develop and compare global service support strategies.

• Background to FDA`s Inspection authority
• The background to changing FDA approaches
• The knowledge to help you prepare to successfully host an FDA inspection
• Common FDA inspection target areas/systems
• Running an inspection ready room
• Help in interpreting what a Form 483 actually states and how to formulate your response

IIR’s Telecoms Cloud Services Summit will examine how operators can leverage their core strengths and existing assets to develop and deliver competitive cloud-based services that will differentiate them from other Cloud companies and deliver true value to their customers. Operator case studies and expert presentation will address the internal technical and organisational prerequisites and potential external barriers to the successful deployment and adoption of cloud services. In addition, the event will explore the various cloud service models (SaaS, IaaS, PaaS) and service model combinations that are emerging and that will enable operators to create new and sustainable revenue streams. 

The Summit will feature practical operator case studies, expert presentations as well as interactive and informal discussion sessions that will enable delegates to find answers to their most pressing questions. The exhibition accompanying the Summit will give delegates the opportunity to network with industry experts and explore the latest Cloud Computing solutions.

The other important issue regarding the SmPC is EU harmonisation, and this meeting will consider procedures for harmonisation emphasising articles 29 and 30, and outline experience to date from both a regulatory and industry point of view.

TOPICS TO BE COVERED AT DURING THIS MEETING:

• EU SmPC: Significant and interesting changes in the Guidance
• Industry view of changes to the SmPC guidance
• EU Harmonisation of the SmPC: articles 29 and 30 harmonisation
• Industry view of harmonisation
• The SmPC and the Package Leaflet

Taking place in London, UK, this conference will look at a wide range of issues within the HTS arena under several `topic umbrellas`.  The State of the Industry will look at the best of HTS now, outsourcing and hit-to-lead bottlenecks.  Focussing HTS will investigate methods to increase the quality of the leads generated.  There will be in-depth studies into In-Silico Screening and GPCRs, and finally, a look to the future in New Screening Technologies.

Questions examined during the conference will include: how successful is HTS now?  Is outsourcing worthwhile economically?  What are the IP issues?  Can intelligent research outperform HTS?  Does iterative screening hold the key to obtaining high quality leads?  How can we redesign the HTS framework?  Do we rely on established assays too much?  Can virtual screening ever replace HTS as the standard lead generator?  How can HTS be used successfully in harnessing the power of GPCRs?  What is the potential for biophysical tools to be used in screening?

Attend this event to discover how High Throughput Screening can be made more intelligent, more focussed and more beneficial in drug discovery

Key Benefits:

• Examine the efficient methods of immunogenicity testing
• Assess immunogenicity risk assessment strategies
• Evaluate the impact of immunogenic responses on efficacy and safety
• Analyse the strategies for pre-clinical immunogenicity testing
• Discover how to address immunogenicity issues related to formulation
• Gain an insight into the impact of anti-drug IgE antibody testing
• Hear case study updates from top biopharmaceuticals on immunogenicity
• Understand immunogenicity from a practical physician`s perspective

The conference will feature a fully interactive programme, with key presentations and interactive sessions addressing a range of in-depth topics including:

• Using performance measurement to reduce operational costs

• Developing a customer-centric SQM framework

• Understanding how to measure the performance of you HSPA network

• Analysing the latest developments in LTE testing

• Monitoring mobile backhaul performance to maintain optimal end-to-end service quality

• Measuring the performance of UMTS deployed in the 900 MHz band

In an original format this European first PI Visionary Council provides reflection on the role of Process Excellence in transforming business and moving into the economic upturn

• How to prepare yourself for the key reinsurance claims issues facing the market in 2010 and beyond
• The latest developments in Asbestos Claims in Europe, the UK,  the US and key emerging markets 
• Implications of the Damages (Asbestos-Related Conditions) (Scotland) Act 2009 for pleural plaques and related claims
• How evolving case law such as Wasa v Lexington or Equitas v R&Q will impact claims handling behavior
• The changing legal landscape for Class Action in Europe: how close are we to US style class action in Europe and what are the implications for the reinsurance industry?
• Personal injury claims: how to adjust to the upward trend for increasing claims cost in Continental Europe, including an update on Eastern Europe
• Long term claim payments for personal injury and periodic payment orders in the UK: how to determine today how someone will receive for the rest of his life?
• Correctly determine your exposure:  An update on the interpretation of  the key clauses of the Reinsurance Contract in the US, UK and Europe
• The likely impact of Lloyds’ new claims transformation process upon the lead and the following market

If you want to safeguard against potential losses and maximise your profits you need to make sure you attend this conference no matter what it takes! You will thank yourself later!

SMi`s 7th Controlled Release conference will provide you with the latest updates in this area, including controlled release development strategies, practical issues in developing controlled release therapeutics and information on the latest advances in delivery methods.

Key topics to be addressed at the conference include:

• The application of advanced science & technology to develop controlled release dosage forms
• Controlled Release - the role of intellectual property in maintaining and growing market share
• Controlled release in chronic diseases
• Overcoming the blood brain barrier
• Modified release multiparticulates 
• Hot melt extrusion: How to enhance dissolution rate by solid dispersions
• Developing novel inhaled controlled release therapeutics 

In these times of financial downturn, governing bodies, clubs, teams and brands, must, more than ever, examine very carefully the way that they protect and leverage media rights and sponsorship in order to remain attractive in an increasingly competitive sports market. On the regulatory/governance side, sport simply must address the issues of cheating and drugs in order to maintain credibility.

For Pharmaceutical, Biotech and Medical Devices companies, ensuring quality and economic efficiency are top of the agenda. The more streamlined your processes, from R&D to supply chain to manufacturing, the better the chances of beating your competitors. As Lean, Six Sigma and Continuous Improvement projects gather momentum in an ever competitive and changing market, successfully implementing process excellence initiatives has never been as important.

With the significant increase in M&A activity, merged organisations are now also having to accurately determine how to define, analyse, engineer and integrate process across multiple business units. These are neither quick nor easy challenges. But they are crucial to realising the projected benefits of mergers and to ensure the new company operates in a more efficient, cost-effective, process-driven way.

The aim of the conference is to challenge and inspire the water and environmental community by sharing knowledge and best practice, which is at the heart of meeting key global challenges.

In April 2010 CIWEM will hold a two-day Annual Conference that will address multidisciplinary issues across all areas of the global water and environment sector. There will be a mix of keynote speakers, offered papers, exhibitions and networking opportunities that will make this the key event for water and environment professionals.

The topics that are likely to be covered include:

• Flooding, urban drainage, surface water management, and the integration of water and flood management
  Sustainability.
• Climate change; mitigation and adaptation, food, energy and water security.
• Catchment, river basin and watershed management approaches, collaborative working.
• Water management – water resources, water quality, wastewater management, integrated water resource management.
• Environment sector policy, legislation and regulation, the political process.
• Investment and innovation; the opportunities and challenges of greening the economy.
• Societal impacts including arts and culture, well being, health, faith, and diversity on water and environmental issues

• A greater understanding of the evidence base for diagnosis of schizophrenia
• Comprehensive overviews of the current psychological and pharmacological treatment strategies including best practice in prescribing and monitoring medication and the role of CBT
• A raised awareness of the problems and solutions of managing psychosis during
• pregnancy
• Insights into the development of improved care pathways for co-occuring conditions
• An opportunity to share and exchange ideas with leading practitioners in the field

Focusing on the latest technologies and processes Biomass to Liquids 2010 brings together experts from a wide range of disciplines. Technology developments, project updates, policy and regulation and the feedstock debate will all be addressed in this comprehensive two-day event.

SMi’s 3rd annual Financing Nuclear Power conference will bring together key experts and decision makers to share their experiences, offering practical advice and considering the realistic options for financing nuclear power in 2010.

Key topics include:

• The nuclear renaissance in the UK
• Financing new nuclear – challenges for the utility
• Decommissioning – successfully managing the costs
• Operational waste handling and storage - opportunities and risks
• Nuclear - an integral part of the future fuel mix
• From plan to production – insurance aspects
• Project management: from licensing to power generation
• Political lobbying for nuclear power
  

Join us for SMi`s 13^th annual Generics, Super-Generics and Patent Strategies and discover the future of the generics market. Hear experts in the field discuss the latest patent strategies, regulatory updates and growth strategies that will be key to the future of the industry.

Key topics include:

• Examine the legal framework and litigation mechanics in both the EU and US 
• Latest legislative and regulatory updates in generics and biosimilars
• Identify key growth areas and methods to take advantage of these
• M&A activities and their implications
• New business models
• Emerging markets
• R&D in generics

In October 2008 the Government announced its intention to mandate a roll out of electricity and gas smart meters to all homes in Great Britain with the aim of completing the roll out by the end 2020. The Government published a ‘Consultation on Smart Metering for Electricity and Gas on 11 May 2009. This Consultation was aimed at confirming the shape and high-level requirements for the domestic roll-out. It also set out proposals to mandate a smart/advanced meter roll out for small and medium non-domestic sites.

Decisions set out in the Government Response Document provide the platform to launch the major programme of implementation work that will be needed to ensure that the Government’s goal of a full roll-out of smart meters by the end of 2020 is successfully achieved. To realise all the benefits fully, the roll-out of smart meters will need to be effectively designed, planned and co-ordinated at every stage. A major programme of work therefore needs to be taken forward under an Implementation Programme before the mass roll out of smart meters begins.

Join over 300 senior level industry experts during Smart Metering UK & Ireland 2010 and discuss the way forward in Europe’s largest smart metering roll-out!

Key themes:
• An overview of cell culture technology: The latest developments on cell-culture based vaccine production
• Cell line selection and development
• Mammalian cell culture processes for large scale operation
• Glycan analysis in cell culture-based influenza vaccine production
• Influence of host cell line and virus strain on the glycosylation pattern of viral Haemagglutinin
• Bulk Production, microcarrier cultures and free-cell suspension cultures
• Downstream processing parameters for purification, filling, and packaging of the cell culture based vaccines
• Flow cytometric monitoring of influenza virus infection
• Validation of cell culture based processes & qualification of associated equipment and facility
• Analysing ventures of global vaccines manufacturers in the developing world
• Regulatory issues associated with the development of cell-based influenza vaccine

SMi’s Retail Cards and Payments Conference will shine a spotlight on the market and provide a comprehensive analysis on all forms of retail payments from loyalty schemes and gift cards to vouchers and open-loop prepaid cards. Discover how they interact, the impact of new technology and most importantly; what the consumer really wants from its retailers.   

With an exceptional line up of speakers covering all of the most important issues, this is an unmissable opportunity to learn and network with the key personnel in the Retail Cards and Payments market. Book now to avoid missing out. 

SMi`s 4th annual Clinical Trial Logistics conference will address your concerns and provide you with the tools to safely and efficiently resolve your clinical trials logistical challenges on a global scale. This conference will also analyse the latest developments in labelling, packaging, inventory management, security, forecasting, partnering and outsourcing.

Key Benefits:
• Examine DNA and RNA structure, function and sequence analysis
• Assess the challenges of data integration
• Evaluate the advantages of proteomic analysis to the drug industry
• Analyse the future regulatory environment
• Receive an update on the global informatics software market
• Gain an insight into the bioinformatics application in drug discovery
• Be part of a unique networking opportunity

TNMO brings together over 200 senior professionals in your industry. It`s a unique forum at which you can:

• meet your peers from other mobile operators` transport departments
• find out how other operators are adapting their transport infrastructure to meet changing commercial and customer requirements
• compare the different evolution options offered by full solution and specialist vendors
• benchmarking your evolution plans with those of industry experts and your peers

Be a leader among the leaders in search marketing by attending. Influencing industry developments is an essential mission of SMX Advanced, which connects search marketers, decision makers from the search engines, and other key industry stakeholders. You’ll participate in conversations orchestrated to debate thorny issues and move the industry forward.

And there will be plenty of learning and sharing. The most accomplished search marketers in the world will present cutting edge tips for driving traffic and increasing conversions from paid search advertising, SEO, social media marketing, search analytics and more.

Convenience is an SMX Advanced hallmark:

• Need to stay connected? Our session rooms have Wifi. For free. For everyone.
• Need to plan your time? Use our SMX Connect social networking tool to meet others pre-show, develop your custom itinerary and reserve your place at birds-of-a-feather lunches.
• And don’t worry about finding something tasty and nourishing to eat. Breakfast, hot lunches, snacks and beverages are all included.

Finally, SMX Advanced is intentionally intimate, so you’ll be certain to meet the people you want to meet. This conference sold out in good times and bad each of the three years since it started in 2007. We could relocate and sell more tickets, but the ingredients — the content, networking, and energy — are too precisely formulated to change.

Experts from over 40 top global and national brands will teach you how they are:

• Establishing a marketing metrics baseline
• Correlating offline and online measurements
• Connecting customer satisfaction data with customer behavior data
• Comparing online to other channels of acquisition and distribution
• Changing a corporate culture to embrace marketing experimentation
• Increase measurable value from your website, campaigns and communications
• Demystify the website audit process
• Discover web analytics basics at the Web Analytics Association (WAA) Base Camp - Introduction to Web Analytics and Search Analytics for Search Marketers
• We’ve been influencing customers through social media, but are we measuring results? Do we know what those measures are? Take your understanding of social media metrics to the next level
• Learn how best use of data, technology and processes improves the online customer experience and builds loyalty.
• Learn how companies are increasing marketing performance offline by listening and learning from customers online
• Discover how to create an analytics-based marketing and business culture
• Learn how to build a case for online marketing analytics, secure a budget and resources
• See hands-on demonstrations of the latest tools in action
• See case studies presented by senior web and ecommerce managers, marketers and analysts

Who Should Attend

A comprehensive course designed for all personnel in the Pharmaceutical Industry new to or already dealing with Regulatory Affairs in Africa including South Africa.

Topics to be covered at this meeting:

• The Markets
• The Development of Drug Control
• Company and Product Registration
• Compilation of the Dossiers
• Regulatory Submission Strategy
• Agency Assessment
• Recent Developments in South Africa
• Interactive Workshop: Putting Learning into Practice
• Harmonisation and Co-operation Initiatives in Africa
• General Country Specific Discussion

Leading authorities on nuclear waste management will share their knowledge and experiences to help you steer through 2010 and beyond, with specifically tailored case studies including:

• Creating a very strong interim storage agenda before the repository programme arrives
• Interim storage of spent nuclear fuel at Ignalina NPP
• Recent developments in technical guidance for the management of HLW’s
• Heading towards a global optimisation of waste management scenarios including waste packaging, transportation, interim storage and disposal
• Safety principles for the design of up-to-date storage facilities
• Measures to assure the disposability of radioactive waste following long term storage

The conference will bring together researchers from all over the world to celebrate current achievements in breast cancer research and provide an excellent opportunity to network with key researchers, share knowledge, exchange ideas and build collaborations.

As registration and abstract submission will be open to all individuals with an interest in breast cancer research and not restricted to Campaign-funded researchers, we hope you will be able to join us.

We look forward to welcoming you to London in May 2010.

Best wishes

Dr Suzanne Eccles
Chair

Professor Gareth Evans
Deputy Chair

• Communicating and clarifying your rewards package to ensure employees fully understand the value
• Empowering line managers to take ownership for the reward package
• Non-financial vs. financial rewards – making non-financial rewards valuable
• Financial education –increasing pension take-up and advising on financial savings in an economic downturn
• Adapting your rewards and benefits strategy in times of change: rewards acting as a support mechanism
• Measuring and evaluating the business benefits of your reward package: what is the impact on the bottom line?
• Identifying which factors keep employees working for you: how do you implement change in a package and convince employees they are not losing out?
• Retaining and engaging talent through rewards – how can reward support the succession plan?
• Achieving the right behavioural response: utilising reward to maximise both the internal and external brand to become the employer of choice
• Trends in executive reward
• Tailoring reward to the individual: offering flexible benefits and a greater choice
• Opportunities for staff through learning and development
• Effect of Corporate Social Responsibility on employee benefits
• Adjusting to a flexible working practice and supporting employees in times of personal crisis
• Fresh, simple and creative reward ideas

• Insights into effective sexual health promotion and STI prevention
• Expert opinions into developing accessible sexual health and contraceptive services
• Greater understanding of the diagnosis and clinical management of viral STIs including HIV
• Discussions about the management of STIs during pregnancy and in young people
• Further understanding of the psychological issues in sexual health
• Updates on advances in diagnosis and treatments of bacterial infections such as syphilis, NGU and gonorrhoea
• An opportunity to share and exchange ideas with leading practitioners in the field

By attending this conference, you will:
• Discuss emerging trends in electronic submissions in the US & Europe, Filing CTDformatted 
• Identify challenges and benefits of transitioning to eCTD
• Hear the various methods of submitting electronic submissions to global health authorities
• Learn how to manage the lifecycle of an eCTD
• Understand if outsourcing is a rapid, cost-effective option for electronic submissions
• Recognise the vital role of good document management and best business practices in the overall process of preparing the eCTD
• Describe the role of eCTD standards and analysing their impact to the development/delivery process.

By attending this conference, you will gain key insights into the hottest topics and main drivers in mAb research and development today, including:
• Oligonucleotide, and new scaffold and next generation technologies
• The importance of isotyping in preclinical modelling
• New data from clinical trials for conjugated and unconjugated therapies
• Identifying and validating cell-surface antigens for antibody targeting
• Prospects for fragment monoclonal antibodies
• Overcoming immune reactions to improve clinical applications of antibody therapeutics
• Reducing inflammation and tissue damage in central nervous system diseases
• Market impact and post-marketing issues
• Prospects for inhibiting angiogenesis
• Perspectives on antibody process development including sharing IP, or implementing and licensing commercial process technologies
• Challenges facing implementation of anti-solid/liquid tumour therapies 

As more and more pharmaceutical products enter the market, the challenges associated with protecting a patent portfolio on an international scale are becoming increasingly complex. Furthermore, as the number of patents scheduled to expire hits record levels, there is mounting pressure to strengthen and protect both existing and new patents in order to secure the profit generated by patented products. Consequently, Pharmaceutical & Biotech Patent Litigation Strategies 2010 will provide you with an invaluable opportunity to learn the best approaches to navigate the ever evolving international IP landscape to ensure that your patent portfolio is protected and ultimately, that your product revenue is maximised.

Designed for Oil & Gas underwriters and other professionals in the upstream sector, this excellent event will cover the following areas and much more:

• What is the outlook for the energy insurance market for 2010 and beyond? – Panel discussion
• The latest developments in technology relating to oil & gas exploration and production
• Analysis of risks and coverage in the Gulf of Mexico – panel discussion
• Assessing risk with deep water coverage – how this impacts on risk assessment
• Business interruption – key issues
• Asset valuation, current strategies
• Control of well cover – understanding the risks from an insurers perspective
• New construction projects and their impact on energy insurance risk evaluation
• Energy insurance claims
• Decommissioning oil platforms

The Customer Insight Exchange offers Heads of Customer Feedback, Customer Insight, Customer Experience and Marketing the opportunity discuss strategies and solutions for extracting accurate and valuable data from multiple channels, applying data analytics and value modelling and creating insight that is actionable. The Customer Insight Exchange is Europe’s only event dedicated to Senior Level Executives responsible for customer insight and intelligence initiatives from global telecom, finance, retail, utility, travel and hospitality organisations.

“Digital and tradition media are converging, but neither government nor industry can keep up.  How can we manage the myriad of conflicting standards and laws around the world?”
Bill Mordan , Senior Vice President and General Counsel, Reckitt Benckiser Plc

Following the enormous success of our 23rd Annual Advertising Law conference in the US, C5 is proud to present its forthcoming inaugural EU Advertising and Marketing Law Conference, the only event of its kind bringing you the latest, the best and the most innovative international brand case studies including:

• The EU Directive - an update on where the directive stands amongst Member States today and what its impact has been to date

• Green Marketing - how to advertise your product and get your message across in an eco-friendly marketplace

• Behavioural Marketing – determine how permissible it is to advertise and market to people based on searches, statistics, data and personal information

• Mobile Marketing, Video on Demand, Social Gaming - gain insight into current trends, on-going challenges and future developments

Plus:

International Panel Session on:

Sponsorship – hear from a panel of experts disclosing the difference between ambush marketing and free competition within their individual jurisdictions

Also:

Join the debate and interact with the leading experts discussing their views on:

• Unfair commercial practices
• Advertising to children
• Product placement

Learn, discuss and gain knowledge on:
• Forced degradation studies: groundwork and practical aspects
• Forced degradation concepts for small and big molecules
• Drug degradation chemistry within drug discovery
• Bioassays for assessing degradation
• Monitoring and evaluation of single amino acid modifications of therapeutic monoclonal antibodies
• Pre-formulation of proteins by high-throughput techniques
• Rapid and robust excipient selection during formulation development
• Comparing two different excipient screening approaches for the same drug
• Integrated approach to detect and quantify genotoxic impurities in APIs
• Quality by Design (QbD) application to GTI control strategy
• In silico Prediction of forced degradation
• Regulatory perspectives on drug degradation and stress testing

EAACI congresses now attract more abstracts and free communications than any other allergy congress worldwide, so we will make a special effort to ensure that everyone who presents new work at EAACI will get the opportunity both to present their work and to take part in discussions with colleagues and experts in their respective fields.

Taking place in London, UK, this conference will look at a wide range of issues withing the pain therapeutics arena.  It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of biomarkers and the cannabinoid approach.

Questions examined during the conference will include: Do cannabinoid medicines have a place in our pain arsenal?  How do regulatory authorities treat emerging clinical development biomarkers.  What are the latest targets being researched?  How do we treat associated conditions for chronic pain?    How effective is translational research for pain measurement?  Attend this event to discover the latest success stories in researching and marketing pain therapeutics. 

Attend and meet with key national decision makers, who will update you on their national SDR programmes. What are the French, Spanish and Italian plans and how are they progressing with research and development? Furthermore, once again hear an update on NATO SDR and the NATO framework.

International Software Radio 2010 will also give you the opportunity to discuss the evolution of SDR with the people that matter. Assess the future and evolution of cognitive radio and learn how your organisation can take advantage of and develop this technology.

Assessing a wide range of military, commercial and humanitarian operations, Air Mission Planning will allow you to analyse the latest operations and experiences in delivering strategic, tactical and operational mission planning for air operations. With a range of presentations, take the opportunity to learn both national MOD and NATO perspectives and requirements.

Network with a senior line up of speakers and ensure that your organisation is at the forefront of providing fully interoperable mission planning systems and support to air operations.

Reasons to register today:
• Understand the use of isothermal calorimetry to characterise stability of amorphous pharmaceuticals
• Implement the latest technological developments
• Discuss the best approaches to control and stabilise amorphous drug forms
• Examine the quantification of amorphous content
• Gain a clearer insight on amorphous food materials
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies

SMi’s inaugural Biogas 2010 will bring together leading industry experts, regulators, financiers and technology providers from all across Europe to help you understand and benefit from the underlying opportunities of Biogas development, especially in the UK. 

Make sure you attend this event and walk away with all the essential knowledge needed to maximise the potential, profitability and sustainability of your business.

At a time when business turbulence and technology diversity are both increasing, Enterprise Architects must make pragmatic decisions about how and where to direct their efforts. They must also evolve their approaches to reflect new business and IT delivery models.

The European Enterprise Architecture Conference attracts a wide range of experienced speakers and delegates from round the world and provides a unique opportunity to discover the approaches that work most effectively.

• Choose from 7 pre-conference seminars and 4 conference tracks.
• Explore what it takes to be a responsive business with agile processes, systems and technologies
• Evaluate what works best in different business environments, and what doesn`t, through practical case studies and examples from Global 2000 companies and major public services
• Gain renewed inspiration and fresh insights into the latest EA thinking and innovations.
• Share ideas and experiences through networking with others in similar situations
• All levels of experience catered for

SMi’s Urban Close Air Support is well timed to provide you with the most up-to-date case studies from CAS operations in Afghanistan. Assess the lessons learned from missions and explore the latest requirements for FAC/JTAC simulation.

Now in its 12th year, this event is your chance to network with an unparalelled line up of international decision makers in the SatCom arena. With delegate and exhibition places sold out once again in 2009, ensure that you book early and guarantee your place alongside 300 industry colleagues at the SatCom event of the year.

Over the years, Global MilSatCom has led the way in offering a diverse range of international military speakers. Meet with and learn from the key European and NATO players and also take the opportunity to learn from an array of other significant global SatCom leaders. From Australia, South Africa, Japan, USA, UAE and Canada, this event is a unique opportunity to meet an international array of SatCom decision makers.

Bubble London runs twice yearly in January and June in sync with the European calendar, and is the only standalone children`s trade event in the UK. It has grown from 60 exhibitors at its launch to over 190 carefully selected brands last season. Throughout this growth, the intimate atmosphere, the attention to detail and the human dimension of the shows have never been compromised. Bubble has become an international reference on the trade show circuit, a must-visit event for anyone with a keen eye on the fast changing and very exciting children`s market.

Trade only.

Bringing you the latest in basic, pre-clinical, translational and clinical research, we showcase the latest in a field rich in opportunities. Updates from outstanding speakers cover:
• Full market analysis including prospects for pipeline therapies 
• New insights into retinal ganglion cell pathology, degeneration and apoptosis
• Innovative in vivo techniques to increase the spatial resolution of retinal imaging for the optic nerve and retina
• Increasing the effectiveness of neuroprotective agents beyond monotherapy
• Defining and validating clinical measures of neuroprotection
• Sustained release intraocular devices to boost patient compliance
• Gene, encapsulated-cell and cell replacement therapies for retinopathies
• Developments in anti VEGF treatments for wet AMD
• RNAi therapeutics for wet AMD and diabetic macular oedema
• Antibody therapies for age-related macular degeneration and diabetic retinopathy

SMi’s 5th annual Energy Risk Management conference will bring together renowned experts to debate on most prominent issues in the industry. The event will provide you the unique opportunity to address concerns and find solutions needed to succeed in these turbulent times.

Now in its 6th successful year, this European Forum on Anti-Corruption Compliance and Enforcement will assemble a leading faculty of experienced in-house and private practice lawyers, compliance executives and government officials who will provide the latest insights to facilitate compliance with anti-corruption laws and mitigate damage should a violation ever happen.

The conference will explore the next generation of protein therapeutics, how they are being developed and reassess the technology, discovery and delivery trends. Also covered will be expression optimisation, case studies looking at successful drugs along with immunogenic considerations and safety assessment.

Reassess the latest therapeutics, developments, technologies, and methods that work in an interactive, networking friendly environment with major players from the biotech industry.

This meeting will feature talks from experts who will address:

• Optimisation of pre-formulation approaches, expression and glycosylation
• Next generation nanobodies
• Generating therapeutic antibodies to multi-transmembrane receptors
• Case studies in successful innovative biotherapeutics
• In silico methods to reduce development risks
• Recognising and combating immunogenicity
• Regulatory perspectives

Extending the a product’s patent lifecycle has become increasingly important in the pharmaceutical industry. High R&D costs and the lengthy product testing times that are required before products can enter the market make it particularly important for companies to be able to extend their product exclusivity.

Maximising protection and value from extending the life of a patent has become more and more complex as patent, competition and regulatory law continually changes. Ground-breaking case law, legislative developments and evolving regulation mean that the rules of the game for effective patent lifecycle management and extension are constantly changing.

In this fast changing high stakes industry it is imperative to have an up-to-the-minute in-depth understanding of the decisions of the European and US courts and the very latest practices in Europe and the United States, including with the European Competion Commision.

In response to this, C5 has specifically designed its Pharma Patent Lifecycle Extension Conference to provide you with a sophisticated and comprehensive understanding of the issues you face today and offers you practical solutions. It will tell you everything you need to know from initial patent filing to obtaining regulatory data exclusivity. The will bring you up to date with the latest legal developments and offers the best practical solutions to your patent lifecycle management.

The 9th C5 Conference on Pharma Patent Lifecycle Extension brings together a panel of experts comprising regulators, leading patent practitioners and senior lawyers who will provide you with practical knowledge and strategic advice on:

• The Impact of Regulatory Data Protection on Lifecycle Management
• Recent Trends and Developments in Supplementary Protection Certificates and Paediatric Extensions
• The Latest Status of the European Competition Commision and the Dawn Raids
• Using Second Medical Use Claims to Extend Patent Lifecycles
• Collaboration to Extend Lifecycle
• How to Optimise Your Product`s Lifecycle Through Successful Global Patent Lifecycle Management
• Industry Case Study and Break Out Session: Insight into Pfizer`s European Lipitor Litigation

C5’s Forum on Anti-Corruption, London Edition is THE annual event that continues to bring together key industry leaders and government representatives in order to discuss the critical issues and best practices for companies to improve their anti-corruption and anti-fraud policies in this ever changing landscape.

Share your knowledge and expertise with your industry peers and colleagues. Gain greater industry recognition as you join our group of business leaders who have helped to shape some of our most important industry conferences. This is an outstanding career, business networking and information sharing opportunity.